Bär & Karrer advised Tecan on the inaugural issuance of CHF 250m Bonds
Tecan Group, a global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics, has successfully issued CHF 250 million 0.50% bonds due 2025. The bonds will be listed and traded on the SIX Swiss Exchange. The settlement will be on 6 October 2021.
The net proceeds of the issue will partly refinance the USD 1.0 billion (CHF 920 million) acquisition of Paramit Corporation, the OEM developer and manufacturer of medical devices and life science instruments, that was announced on June 23, 2021 and successfully closed on August 2, 2021.
The bonds were placed with institutional investors and private banks in Switzerland under the joint lead management of Credit Suisse and Zürcher Kantonalbank.
Bär & Karrer acted as legal advisor to Tecan. The team included partner Ralph Malacrida (pictured), partner Lukas Roesler, junior associates Clarissa Marxer and Nico Hunziker (all capital markets and corporate) as well as partner Susanne Schreiber and associate Elena Kumashova (both tax).
